Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Vyant Bio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −6 vs. Q2 2021
- Shares held
- 2.26M
- +10.9K (+0.5%) vs. Q2 2021
- Total value
- $5.27M
- −$3.15M (−37.4%) vs. Q2 2021
- New holders
- 1
- 6 more added
- Sold out
- 7
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $1 |
| Q1 2023 | 17 | $136.8K |
| Q4 2022 | 17 | $222.1K |
| Q3 2022 | 26 | $949.3K |
| Q2 2022 | 21 | $1.47M |
| Q1 2022 | 23 | $2.54M |
| Q4 2021 | 27 | $3.12M |
| Q3 2021 | 23 | $5.27M |
| Q2 2021 | 29 | $8.41M |
| Q1 2021 | 18 | $2.96M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Vyant Bio, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 851,507 | $1.98M | 0.00% | +12,281+1.5% | Added |
| BlackRock Inc. | 210,460 | $490.0K | 0.00% | −1,668−0.8% | Reduced |
| Blankinship & Foster, LLC | 205,094 | $478.0K | 0.19% | 00.0% | Unchanged |
| Frontier Wealth Management LLC | 202,601 | $472.0K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 188,802 | $439.0K | 0.00% | +12,122+6.9% | Added |
| Cerity Partners LLC | 119,535 | $279.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 109,200 | $254.0K | 0.00% | +109,200 | New |
| Taylor Wealth Management Partners | 82,197 | $192.0K | 0.07% | −3,424−4.0% | Reduced |
| State Street Corp | 65,671 | $153.0K | 0.00% | +12,900+24.4% | Added |
| Northern Trust Corp | 43,901 | $102.0K | 0.00% | 00.0% | Unchanged |
| First Republic Investment Management, Inc. | 41,009 | $96.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 38,050 | $89.0K | 0.00% | +10.0% | Added |
| Jackson Square Capital, LLC | 30,389 | $71.0K | 0.02% | 00.0% | Unchanged |
| Country Club Trust Company, n.a. | 20,000 | $47.0K | 0.00% | 00.0% | Unchanged |
| NorthRock Partners, LLC | 18,832 | $44.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 16,110 | $38.0K | 0.00% | +3,328+26.0% | Added |
| Carlson Capital Management | 11,800 | $27.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,456 | $8.00K | 0.00% | −6,940−66.8% | Reduced |
| US Bancorp | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 256 | $1.00K | 0.00% | +6+2.4% | Added |
| Advisor Group Holdings, Inc. | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 162 | $0 | 0.00% | −28−14.7% | Reduced |
| Captrust Financial Advisors | 50 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 0 | $0 | 0.00% | −56,017−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,035−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,504−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −13,043−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,299−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −10−100.0% | Sold out |